Generic Name: toremifene
Drug Class: Hormone Therapy Medications
Company: Kyowa Kirin
Approval Status: Approved
Generic Version Available: No
Fareston is a selective estrogen receptor modulator approved for the treatment of metastatic breast cancer in postmenopausal women with estrogen receptor-positive tumors or those with unknown receptor status.
The female hormone estrogen promotes the growth of estrogen receptor-positive breast cancer. Evista works blocking these receptors and preventing estrogen from binding to cancer cells. It has selective activity against breast cancer while having estrogen-like activity elsewhere in the body.
Fareston is taken as a once-daily tablet.
Common side effects include hot flashes, nausea and vaginal dryness or discharge. Potential serious side effects may include heart rhythm abnormalities, liver toxicity and increased risk of uterine cancer. Fareston should not be used during pregnancy.
For More Info: http://fareston.com
Patient Assistance Program Info: http://fareston.com/support.html
Last Reviewed: December 6, 2018